HealthCap invests in AMRA Medical’s international expansion
The life-sciences investor backs product development and commercial growth, with managing partner Mårten Steen joining AMRA’s board.
Investment paired with a board appointment
AMRA Medical announced an investment from HealthCap on September 14, 2026. The amount was not disclosed. HealthCap managing partner Mårten Steen will join the board, adding the investor’s life-sciences experience and network as AMRA expands its quantitative MRI business.
Broadening research and clinical use
AMRA said the capital would support continued research and development, product innovation and international commercial expansion. The company linked the investment to growing demand in metabolic and neuromuscular medicine for standardized muscle and fat measurements. Its next phase is focused on translating an established scientific base into wider research and clinical applications.
Use of funds
Continue research and development, product innovation and international commercial expansion.